m+Medelevator.RU
← Поиск публикаций
Journal of affective disorders · 2026

Multimodal machine learning model integrating electroencephalography, heart rate variability and clinical measures for distinguishing major psychiatric disorders.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kang Byeongjae, Lee Ji-Yoon, Chang Jeong Woo, Lee Hyunho, Park Minkyung, Baek Ji Hyun, Chung Myung Jin, Kim Taeyoung, Choi Jung-Seok

Аннотация

BACKGROUND: This study aimed to develop and evaluate multimodal machine learning (ML) approaches for differentiating bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SZ), conditions that are clinically difficult to distinguish because of overlapping symptom presentations despite their distinct long-term treatment and management needs.

METHODS: We analyzed a retrospective cohort of 1035 patients (406 BD, 522 MDD, and 107 SZ) using multimodal data, including demographics, clinical scales, heart rate variability, and high-dimensional sensor- and source-level electroencephalography (EEG). To reduce the dimensionality of EEG features, we applied a two-step feature selection procedure combining analysis of variance and recursive feature elimination with cross-validation. We then trained and compared the diagnostic performance of unimodal versus multimodal ML models.

RESULTS: The multimodal ML model based on the CatBoost algorithm achieved an AUROC of 0.776, outperforming all unimodal approaches in differentiating these psychiatric disorders. Delta-, alpha-, and gamma-band phase lag and coherence between frontal, central, and occipital regions emerged as important EEG connectivity features for distinguishing the disorders.

CONCLUSIONS: These findings suggest that multimodal ML may improve the differentiation of SZ, BD, and MDD and may have potential as a decision-support tool, although external and prospective validation is required before clinical implementation.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты